Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

  • LAST PRICE
    8.4400
  • TODAY'S CHANGE (%)
    -0.4000 (-4.5249%)
  • Bid / Lots
    8.3000/ 5
  • Ask / Lots
    8.4300/ 2
  • Open / Previous Close
    8.8700 / 8.8400
  • Day Range
    8.2400
    8.9900
  • 52 Week Range
    4.5200
    11.5550
  • Volume
    3,751,957

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
MRVI
Maravai LifeSciences Holdings Inc
2.2B
-8.5x
---
ZLAB
Zai Lab Ltd
2.1B
-7.1x
---
KNSA
Kiniksa Pharmaceuticals Ltd
1.9B
-143.4x
---
GLPG
Galapagos NV
2.0B
55.8x
---
BEAM
Beam Therapeutics Inc
2.1B
-14.5x
---
CDNA
CareDx Inc
1.6B
-9.9x
---
As of 2024-09-21

Company Information

Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. The Company operates through two segments. Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acid products to support the needs of customer research, therapeutic and vaccine programs. The segment also provides research products for labeling and detecting proteins in cells and tissue samples. Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities.

Contact Information

Headquarters
10770 Wateridge Circle Suite 200 Suite 200SAN DIEGO, CA, United States 92121
Phone
858-546-0004
Fax
302-655-5049

Executives

Executive Chairman of the Board
Carl Hull
Chief Executive Officer, Director
William Martin
Chief Financial Officer
Kevin Herde
President - Nucleic Acid Production
Andrew Burch
Executive Vice President, Chief Commercial Officer
Rebecca Buzzeo

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$2.2B
Revenue (TTM)
$278.6M
Shares Outstanding
252.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.01
EPS
$-1.00
Book Value
$1.66
P/E Ratio
-8.5x
Price/Sales (TTM)
8.0
Price/Cash Flow (TTM)
---
Operating Margin
-18.29%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.